STAT5 is clearly required for the development of CML since Stat5a/b deletion suppresses disease initiation and maintenance in mouse models of BCR-ABL1-dependent leukemia [19,20]. The gene discussed is STAT5B; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.